Aug 9 (Reuters)-
Human Metabolome Technologies, Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 30, 2024 Jun 30, 2023 Jun 30, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.35 1.30 1.50
(+3.6 pct) (+6.2 pct) (+11.5 pct)
Operating 220 mln 210 mln 260 mln
(+4.4 pct) (+10.4 pct) (+18.1 pct)
Recurring 241 mln 232 mln 280 mln
(+3.8 pct) (-8.1 pct) (+16.0 pct)
Net
Net 243 mln 285 mln 280 mln
(-14.9 pct) (+6.7 pct) (+15.1 pct)
EPS 41.14 yen 48.39 yen 47.33 yen
Ann Div 15.00 yen 10.00 yen 15.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 15.00 yen 10.00 yen 15.00 yen
NOTE - Human Metabolome Technologies, Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6090.T